{"id":347257,"date":"2025-08-25T11:23:30","date_gmt":"2025-08-25T11:23:30","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-krystal-biotech\/"},"modified":"2025-08-25T11:23:31","modified_gmt":"2025-08-25T11:23:31","slug":"how-to-buy-krystal-biotech","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/","title":{"rendered":"Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Krystal Biotech, Inc. (KRYS) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-347257","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Krystal Biotech, Inc. (KRYS) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Krystal Biotech, Inc. (KRYS) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Krystal Biotech, Inc. (KRYS) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu umut vadeden gen terapisi hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. Ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 i\u00e7in g\u00fcncel fiyat, trendler ve uzman analizlerini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Krystal Biotech, Inc. (KRYS) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu umut vadeden gen terapisi hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. Ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 i\u00e7in g\u00fcncel fiyat, trendler ve uzman analizlerini ke\u015ffedin."},"intro":"Gen terapisi gelece\u011fine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Krystal Biotech, bug\u00fcn biyoteknolojideki en heyecan verici f\u0131rsatlardan birini temsil ediyor. Nadir hastal\u0131klar i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an tedaviler ve genetik t\u0131pta devrim niteli\u011finde bir yakla\u015f\u0131m ile bu \u015firket hem sa\u011fl\u0131k hizmetlerini hem de yat\u0131r\u0131m portf\u00f6y\u00fcn\u00fcz\u00fc d\u00f6n\u00fc\u015ft\u00fcrebilir. KRYS'nin neden dikkatinizi hak etti\u011fini birlikte ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Gen terapisi gelece\u011fine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Krystal Biotech, bug\u00fcn biyoteknolojideki en heyecan verici f\u0131rsatlardan birini temsil ediyor. Nadir hastal\u0131klar i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an tedaviler ve genetik t\u0131pta devrim niteli\u011finde bir yakla\u015f\u0131m ile bu \u015firket hem sa\u011fl\u0131k hizmetlerini hem de yat\u0131r\u0131m portf\u00f6y\u00fcn\u00fcz\u00fc d\u00f6n\u00fc\u015ft\u00fcrebilir. KRYS'nin neden dikkatinizi hak etti\u011fini birlikte ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 Krystal Biotech Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla, Krystal Biotech, Inc. (KRYS) NASDAQ borsas\u0131nda <strong>146,04 $<\/strong> fiyatla i\u015flem g\u00f6rmektedir. Bu fiyat, hissenin son performans\u0131 ve gelecekteki potansiyeli g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda ilgin\u00e7 bir giri\u015f noktas\u0131d\u0131r.<\/p> <p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131:<\/strong> Takviminize <strong>3 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin. Bu tarihte Krystal Biotech, piyasa a\u00e7\u0131lmadan \u00f6nce bir sonraki kazan\u00e7 raporunu yay\u0131nlayacak. Tarihsel olarak, bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden olmu\u015ftur.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 KRYS Hissesini Nas\u0131l Etkiler?<\/h3> <p>Son tarihlere bak\u0131ld\u0131\u011f\u0131nda, Krystal Biotech'in kazan\u00e7 a\u00e7\u0131klamalar\u0131 hissenin hareket etmesine s\u00fcrekli neden olmu\u015ftur:<\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>4 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>138,66 $<\/td><td>+2,56 (+%1,88)<\/td><\/tr> <tr><td>5 May 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>142,10 $<\/td><td>-3,44 (-%2,42)<\/td><\/tr> <tr><td>10 \u015eub 2025<\/td><td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td><td>148,90 $<\/td><td>+5,20 (+%3,49)<\/td><\/tr> <tr><td>4 Kas 2024<\/td><td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>140,25 $<\/td><td>+7,85 (+%5,60)<\/td><\/tr> <tr><td>5 A\u011fu 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>132,40 $<\/td><td>+8,26 (+%6,24)<\/td><\/tr> <tr><td>6 May 2024<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>125,80 $<\/td><td>+6,60 (+%5,25)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Bilgisi:<\/strong> 4 A\u011fustos 2025 kazan\u00e7lar\u0131 \u00f6zellikle etkileyiciydi - \u015firket, tahminlerin \u00fczerinde 1,29 $ EPS (beklenti 1,08 $; %19,44 s\u00fcrpriz) ve 96,04 milyon $ gelir (beklenti 95,42 milyon $) bildirdi (<a href=\"https:\/\/www.nasdaq.com\/articles\/krystal-biotech-inc-krys-tops-q2-earnings-and-revenue-estimates\">Nasdaq Raporu<\/a>). Bu g\u00fc\u00e7l\u00fc performansa ra\u011fmen, hisse sadece %1,88 de\u011fer kazand\u0131, bu da potansiyel bir d\u00fc\u015f\u00fck de\u011ferlemeye i\u015faret ediyor olabilir.<\/p> <h3>6 Ayl\u0131k Fiyat Seyri (\u015eubat-A\u011fustos 2025)<\/h3> <p>Krystal Biotech son alt\u0131 ayda \u00f6nemli dalgalanmalar ya\u015fad\u0131:<\/p> <p><strong>\u015eubat 2025:<\/strong> 148,90 $ - G\u00fc\u00e7l\u00fc y\u0131ll\u0131k sonu\u00e7lar g\u00fcveni art\u0131rd\u0131<br\/> <strong>Mart 2025:<\/strong> 142,30 $ - Piyasa d\u00fczeltmesi biyoteknoloji sekt\u00f6r\u00fcn\u00fc etkiledi<br\/> <strong>Nisan 2025:<\/strong> 138,75 $ - Sekt\u00f6r genelinde bask\u0131 devam etti<br\/> <strong>May\u0131s 2025:<\/strong> 142,10 $ - 1. \u00e7eyrek kazan\u00e7lar\u0131 destek sa\u011flad\u0131<br\/> <strong>Haziran 2025:<\/strong> 136,50 $ - Yaz volatilite d\u00f6nemi<br\/> <strong>Temmuz 2025:<\/strong> 140,80 $ - Kademeli toparlanma ba\u015flad\u0131<br\/> <strong>A\u011fustos 2025:<\/strong> 146,04 $ - Son kazan\u00e7 art\u0131\u015f\u0131 ile mevcut seviye<\/p> <p>Hisse, 2025 y\u0131l\u0131 ba\u015f\u0131ndan itibaren yakla\u015f\u0131k <strong>%12,59<\/strong> de\u011fer kaybetti (<a href=\"https:\/\/companiesmarketcap.com\/krystal-biotech\/stock-price-history\/\">CompaniesMarketCap<\/a>), ancak bu, \u00f6nceki y\u0131llarda ola\u011fan\u00fcst\u00fc performans\u0131n ard\u0131ndan gelmektedir - 2024'te %25,37 ve 2023'te %56,58 getiri sa\u011flad\u0131.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, beklenenler \u015funlard\u0131r:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu:<\/strong> 168-172 $ aral\u0131\u011f\u0131 (mevcut seviyelerden %15-18 y\u00fckseli\u015f)<\/li> <li><strong>2026 Hedefi:<\/strong> 190-195 $ (potansiyel %30-33 b\u00fcy\u00fcme)<\/li> <li><strong>2028 Projeksiyonu:<\/strong> 240-260 $ (uzun vadeli %64-78 de\u011fer art\u0131\u015f\u0131)<\/li> <li><strong>2030 G\u00f6r\u00fcn\u00fcm\u00fc:<\/strong> 295-320 $ (toplam %102-119 getiri potansiyeli)<\/li> <\/ul> <p>En iyimser tahmin <a href=\"https:\/\/stockscan.io\/stocks\/KRYS\/forecast\">StockScan<\/a> taraf\u0131ndan yap\u0131lm\u0131\u015f olup, 2025 i\u00e7in ortalama fiyat\u0131 264,25 $ ve y\u00fcksek hedefi 300,56 $ olarak \u00f6ng\u00f6rmektedir.<\/p> <p><strong>Sonu\u00e7: G\u00dc\u00c7L\u00dc AL<\/strong> - Mevcut analist konsens\u00fcs\u00fc, 11 analistin \"G\u00fc\u00e7l\u00fc Al\" derecesi verdi\u011fini ve ortalama fiyat hedefinin 205,27 $ oldu\u011funu g\u00f6steriyor; bu da %40,60 y\u00fckseli\u015f potansiyeline i\u015faret ediyor (<a href=\"https:\/\/stockanalysis.com\/stocks\/krys\/forecast\/\">StockAnalysis<\/a>).<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Y\u00fcksek Volatilite:<\/strong> Biyoteknoloji hisseleri olduk\u00e7a dalgal\u0131d\u0131r - KRYS'nin 52 haftal\u0131k fiyat aral\u0131\u011f\u0131 122,80 $ ile 207,84 $ aras\u0131nda olup %69'dan fazla volatilite g\u00f6stermektedir<\/li> <li><strong>Reg\u00fclasyon Belirsizli\u011fi:<\/strong> Gen terapisi FDA'n\u0131n s\u0131k\u0131 denetimine tabidir - herhangi bir d\u00fczenleyici aksama hisseyi \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir<\/li> <li><strong>Klinik Deneme Riskleri:<\/strong> KB707 akci\u011fer kanseri program\u0131 umut verici olsa da erken a\u015famalardad\u0131r ve geli\u015fim zorluklar\u0131yla kar\u015f\u0131la\u015fabilir<\/li> <li><strong>Piyasa Duyarl\u0131l\u0131\u011f\u0131:<\/strong> G\u00fc\u00e7l\u00fc temellere ra\u011fmen biyoteknoloji sekt\u00f6r\u00fc duyarl\u0131l\u0131\u011f\u0131 temkinlidir<\/li> <\/ul> <h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>G\u00fc\u00e7l\u00fc Finansallar:<\/strong> 2. \u00e7eyrek 2025'te gelir y\u0131ll\u0131k %37 art\u0131\u015fla 96,0 milyon $ ve net gelir %146 art\u0131\u015fla 38,3 milyon $ oldu<\/li> <li><strong>\u00c7\u0131\u011f\u0131r A\u00e7an Tedavi:<\/strong> VYJUVEK, distrofik epidermolizis b\u00fclloza i\u00e7in FDA onayl\u0131 ilk gen terapisidir ve s\u00fcrd\u00fcr\u00fclebilir gelir sa\u011flar<\/li> <li><strong>\u0130la\u00e7 Aday\u0131 \u0130lerlemesi:<\/strong> KB707 akci\u011fer kanseri i\u00e7in inhalasyon program\u0131 %36 objektif yan\u0131t oran\u0131 ve m\u00fckemmel g\u00fcvenlik profili g\u00f6steriyor (<a href=\"https:\/\/www.pharmanow.live\/latest-news\/kb707-lung-cancer-update\">PharmaNow<\/a>)<\/li> <li><strong>Analist Deste\u011fi:<\/strong> Artan \"G\u00fc\u00e7l\u00fc Al\" derecelendirmeleri ile kurumsal g\u00fcven art\u0131yor<\/li> <li><strong>Sekt\u00f6r R\u00fczgarlar\u0131:<\/strong> Gen terapisi pazar\u0131n\u0131n \u00f6n\u00fcm\u00fczdeki \u00fc\u00e7 y\u0131lda y\u0131ll\u0131k %26 b\u00fcy\u00fcmesi bekleniyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <p>T\u00fcm bu fakt\u00f6rlerin analizine dayanarak, i\u015fte tavsiyelerim:<\/p> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5'inden fazla olmayan bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/li> <li><strong>Ortalama Maliyetle Al\u0131m Yap\u0131n<\/strong>: T\u00fcm al\u0131m\u0131 tek seferde yapmak yerine, giri\u015f fiyat\u0131n\u0131z\u0131 ortalamak i\u00e7in al\u0131\u015flar\u0131n\u0131z\u0131 birka\u00e7 haftaya yay\u0131n<\/li> <li><strong>Zarar Durdur Seviyeleri Belirleyin<\/strong>: Volatilite nedeniyle, yat\u0131r\u0131m\u0131 korumak i\u00e7in 135-140 $ civar\u0131nda zarar durdur seviyesi koyun<\/li> <li><strong>3 Kas\u0131m'\u0131 Takip Edin<\/strong>: Bir sonraki kazan\u00e7 raporu, ge\u00e7ici bir zay\u0131fl\u0131k varsa daha iyi bir giri\u015f noktas\u0131 sa\u011flayabilir<\/li> <\/ol> <p>Esprili t\u00fcccar bilgeli\u011fi: \"Biyoteknoloji hissesi almak, fl\u00f6rt etmek gibidir - uzun vadeli ili\u015fki \u00f6d\u00fcllerinin tad\u0131n\u0131 \u00e7\u0131karmak i\u00e7in bazen dramaya katlanmak gerekir!\"<\/p> <h2>\u2705 Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NASDAQ listeli hisseleri sunan ve makul \u00fccretlere sahip oldu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 A\u00e7\u0131n ve Fonlay\u0131n<\/td><td>Risk almaya rahat oldu\u011funuz bir miktarla ba\u015flay\u0131n - 100 $ bile ba\u015flang\u0131\u00e7 i\u00e7in yeterlidir<\/td><\/tr> <tr><td>3<\/td><td>\"KRYS\" Aramas\u0131 Yap\u0131n<\/td><td>Sadece \u015firket ad\u0131 de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Piyasa emirleri yerine giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emir kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve Onaylay\u0131n<\/td><td>Emir detaylar\u0131n\u0131 ve komisyon \u00fccretlerini iki kez kontrol edin<\/td><\/tr> <tr><td>6<\/td><td>Fiyat Uyar\u0131lar\u0131 Kurun<\/td><td>B\u00fcy\u00fck fiyat hareketleri i\u00e7in otomatik bildirimlerle yat\u0131r\u0131m\u0131n\u0131z\u0131 takip edin<\/td><\/tr> <tr><td>7<\/td><td>\u00c7\u0131k\u0131\u015f Stratejinizi Planlay\u0131n<\/td><td>K\u00e2r almay\u0131 veya zarar\u0131 durdurmay\u0131 \u00f6nceden belirleyin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Krystal Biotech ile yat\u0131r\u0131m yolculu\u011funa ba\u015flamak isteyenler i\u00e7in Pocket Option birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Sadece 5 $ minimum depozito<\/strong> - stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in ideal<\/li> <li><strong>Y\u0131ld\u0131r\u0131m h\u0131z\u0131nda KYC s\u00fcreci<\/strong> - sadece bir belge ile dakikalar i\u00e7inde do\u011frulama<\/li> <li><strong>Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil y\u00fczlerce para \u00e7ekme y\u00f6ntemi<\/strong><\/li> <li><strong>Yeni ba\u015flayanlar i\u00e7in \u00f6zel olarak tasarlanm\u0131\u015f kullan\u0131c\u0131 dostu platform ve e\u011fitim kaynaklar\u0131<\/strong><\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, biyoteknoloji yat\u0131r\u0131m\u0131 hakk\u0131nda \u00f6\u011frenirken pozisyonlar\u0131 kademeli olarak olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d 2025'te Krystal Biotech: Gen Terapisi \u00d6nc\u00fcs\u00fc<\/h2> <p>Krystal Biotech, yakla\u015f\u0131k 4,5 milyar $ piyasa de\u011feri ile <strong>ticari a\u015famadaki bir gen terapisi \u015firketi<\/strong> olarak kendini kan\u0131tlam\u0131\u015ft\u0131r (<a href=\"https:\/\/www.bccresearch.com\/company-index\/profile\/krystal-biotech-inc\">BCC Research<\/a>). \u015eirket, nadir hastal\u0131klar i\u00e7in genetik ila\u00e7lar geli\u015ftirmede HSV-1 vekt\u00f6r teknolojisini kullanmaktad\u0131r.<\/p> <p><strong>Onlar\u0131 \u00f6zel k\u0131lan nedir?<\/strong> STAR-D platformlar\u0131, hastalar\u0131n ba\u011f\u0131\u015f\u0131kl\u0131k direnci geli\u015ftirmeden birden fazla tedavi alabilmesini sa\u011flayan tekrarlanabilir gen terapileri sunar; bu alanda b\u00fcy\u00fck bir at\u0131l\u0131md\u0131r.<\/p> <p>\u015eirketin amiral gemisi \u00fcr\u00fcn\u00fc VYJUVEK, distrofik epidermolizis b\u00fclloza i\u00e7in <strong>FDA onayl\u0131 ilk gen terapisidir<\/strong>; bu, a\u011fr\u0131l\u0131 ve sakatlay\u0131c\u0131 genetik bir cilt hastal\u0131\u011f\u0131d\u0131r. Ancak as\u0131l heyecan, \u00f6zellikle erken a\u015famalarda ola\u011fan\u00fcst\u00fc sonu\u00e7lar g\u00f6steren KB707 program\u0131ndan gelmektedir.<\/p> <h3>\u0130lgin\u00e7 Bilgi:<\/h3> <p>A\u011fustos 2025'te Krystal Biotech, yo\u011fun tedavi g\u00f6rm\u00fc\u015f hastalarda %36 yan\u0131t oran\u0131 g\u00f6steren inhalasyon yoluyla uygulanan KB707 akci\u011fer kanseri tedavisini \u00f6nceliklendirdi. Ger\u00e7ekten dikkat \u00e7ekici olan nedir? Bu tedavi, ciddi yan etkisi olmadan ayaktan tedavi ortam\u0131nda uygulanabiliyor - bu da kanser tedavisi eri\u015filebilirli\u011finde devrim yaratabilir (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/21\/3137361\/0\/en\/Krystal-Biotech-Announces-Update-on-Development-Plans-for-Oncology-Program-KB707-and-Prioritization-of-Inhaled-KB707-for-the-Treatment-of-Non-Small-Cell-Lung-Cancer.html\">GlobeNewswire<\/a>).<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Krystal Biotech Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla, Krystal Biotech, Inc. (KRYS) NASDAQ borsas\u0131nda <strong>146,04 $<\/strong> fiyatla i\u015flem g\u00f6rmektedir. Bu fiyat, hissenin son performans\u0131 ve gelecekteki potansiyeli g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda ilgin\u00e7 bir giri\u015f noktas\u0131d\u0131r.<\/p>\n<p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131:<\/strong> Takviminize <strong>3 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin. Bu tarihte Krystal Biotech, piyasa a\u00e7\u0131lmadan \u00f6nce bir sonraki kazan\u00e7 raporunu yay\u0131nlayacak. Tarihsel olarak, bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden olmu\u015ftur.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 KRYS Hissesini Nas\u0131l Etkiler?<\/h3>\n<p>Son tarihlere bak\u0131ld\u0131\u011f\u0131nda, Krystal Biotech&#8217;in kazan\u00e7 a\u00e7\u0131klamalar\u0131 hissenin hareket etmesine s\u00fcrekli neden olmu\u015ftur:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>4 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>138,66 $<\/td>\n<td>+2,56 (+%1,88)<\/td>\n<\/tr>\n<tr>\n<td>5 May 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>142,10 $<\/td>\n<td>-3,44 (-%2,42)<\/td>\n<\/tr>\n<tr>\n<td>10 \u015eub 2025<\/td>\n<td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td>\n<td>148,90 $<\/td>\n<td>+5,20 (+%3,49)<\/td>\n<\/tr>\n<tr>\n<td>4 Kas 2024<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>140,25 $<\/td>\n<td>+7,85 (+%5,60)<\/td>\n<\/tr>\n<tr>\n<td>5 A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>132,40 $<\/td>\n<td>+8,26 (+%6,24)<\/td>\n<\/tr>\n<tr>\n<td>6 May 2024<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>125,80 $<\/td>\n<td>+6,60 (+%5,25)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Bilgisi:<\/strong> 4 A\u011fustos 2025 kazan\u00e7lar\u0131 \u00f6zellikle etkileyiciydi &#8211; \u015firket, tahminlerin \u00fczerinde 1,29 $ EPS (beklenti 1,08 $; %19,44 s\u00fcrpriz) ve 96,04 milyon $ gelir (beklenti 95,42 milyon $) bildirdi (<a href=\"https:\/\/www.nasdaq.com\/articles\/krystal-biotech-inc-krys-tops-q2-earnings-and-revenue-estimates\">Nasdaq Raporu<\/a>). Bu g\u00fc\u00e7l\u00fc performansa ra\u011fmen, hisse sadece %1,88 de\u011fer kazand\u0131, bu da potansiyel bir d\u00fc\u015f\u00fck de\u011ferlemeye i\u015faret ediyor olabilir.<\/p>\n<h3>6 Ayl\u0131k Fiyat Seyri (\u015eubat-A\u011fustos 2025)<\/h3>\n<p>Krystal Biotech son alt\u0131 ayda \u00f6nemli dalgalanmalar ya\u015fad\u0131:<\/p>\n<p><strong>\u015eubat 2025:<\/strong> 148,90 $ &#8211; G\u00fc\u00e7l\u00fc y\u0131ll\u0131k sonu\u00e7lar g\u00fcveni art\u0131rd\u0131<br \/> <strong>Mart 2025:<\/strong> 142,30 $ &#8211; Piyasa d\u00fczeltmesi biyoteknoloji sekt\u00f6r\u00fcn\u00fc etkiledi<br \/> <strong>Nisan 2025:<\/strong> 138,75 $ &#8211; Sekt\u00f6r genelinde bask\u0131 devam etti<br \/> <strong>May\u0131s 2025:<\/strong> 142,10 $ &#8211; 1. \u00e7eyrek kazan\u00e7lar\u0131 destek sa\u011flad\u0131<br \/> <strong>Haziran 2025:<\/strong> 136,50 $ &#8211; Yaz volatilite d\u00f6nemi<br \/> <strong>Temmuz 2025:<\/strong> 140,80 $ &#8211; Kademeli toparlanma ba\u015flad\u0131<br \/> <strong>A\u011fustos 2025:<\/strong> 146,04 $ &#8211; Son kazan\u00e7 art\u0131\u015f\u0131 ile mevcut seviye<\/p>\n<p>Hisse, 2025 y\u0131l\u0131 ba\u015f\u0131ndan itibaren yakla\u015f\u0131k <strong>%12,59<\/strong> de\u011fer kaybetti (<a href=\"https:\/\/companiesmarketcap.com\/krystal-biotech\/stock-price-history\/\">CompaniesMarketCap<\/a>), ancak bu, \u00f6nceki y\u0131llarda ola\u011fan\u00fcst\u00fc performans\u0131n ard\u0131ndan gelmektedir &#8211; 2024&#8217;te %25,37 ve 2023&#8217;te %56,58 getiri sa\u011flad\u0131.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, beklenenler \u015funlard\u0131r:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu:<\/strong> 168-172 $ aral\u0131\u011f\u0131 (mevcut seviyelerden %15-18 y\u00fckseli\u015f)<\/li>\n<li><strong>2026 Hedefi:<\/strong> 190-195 $ (potansiyel %30-33 b\u00fcy\u00fcme)<\/li>\n<li><strong>2028 Projeksiyonu:<\/strong> 240-260 $ (uzun vadeli %64-78 de\u011fer art\u0131\u015f\u0131)<\/li>\n<li><strong>2030 G\u00f6r\u00fcn\u00fcm\u00fc:<\/strong> 295-320 $ (toplam %102-119 getiri potansiyeli)<\/li>\n<\/ul>\n<p>En iyimser tahmin <a href=\"https:\/\/stockscan.io\/stocks\/KRYS\/forecast\">StockScan<\/a> taraf\u0131ndan yap\u0131lm\u0131\u015f olup, 2025 i\u00e7in ortalama fiyat\u0131 264,25 $ ve y\u00fcksek hedefi 300,56 $ olarak \u00f6ng\u00f6rmektedir.<\/p>\n<p><strong>Sonu\u00e7: G\u00dc\u00c7L\u00dc AL<\/strong> &#8211; Mevcut analist konsens\u00fcs\u00fc, 11 analistin &#8220;G\u00fc\u00e7l\u00fc Al&#8221; derecesi verdi\u011fini ve ortalama fiyat hedefinin 205,27 $ oldu\u011funu g\u00f6steriyor; bu da %40,60 y\u00fckseli\u015f potansiyeline i\u015faret ediyor (<a href=\"https:\/\/stockanalysis.com\/stocks\/krys\/forecast\/\">StockAnalysis<\/a>).<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Y\u00fcksek Volatilite:<\/strong> Biyoteknoloji hisseleri olduk\u00e7a dalgal\u0131d\u0131r &#8211; KRYS&#8217;nin 52 haftal\u0131k fiyat aral\u0131\u011f\u0131 122,80 $ ile 207,84 $ aras\u0131nda olup %69&#8217;dan fazla volatilite g\u00f6stermektedir<\/li>\n<li><strong>Reg\u00fclasyon Belirsizli\u011fi:<\/strong> Gen terapisi FDA&#8217;n\u0131n s\u0131k\u0131 denetimine tabidir &#8211; herhangi bir d\u00fczenleyici aksama hisseyi \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir<\/li>\n<li><strong>Klinik Deneme Riskleri:<\/strong> KB707 akci\u011fer kanseri program\u0131 umut verici olsa da erken a\u015famalardad\u0131r ve geli\u015fim zorluklar\u0131yla kar\u015f\u0131la\u015fabilir<\/li>\n<li><strong>Piyasa Duyarl\u0131l\u0131\u011f\u0131:<\/strong> G\u00fc\u00e7l\u00fc temellere ra\u011fmen biyoteknoloji sekt\u00f6r\u00fc duyarl\u0131l\u0131\u011f\u0131 temkinlidir<\/li>\n<\/ul>\n<h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>G\u00fc\u00e7l\u00fc Finansallar:<\/strong> 2. \u00e7eyrek 2025&#8217;te gelir y\u0131ll\u0131k %37 art\u0131\u015fla 96,0 milyon $ ve net gelir %146 art\u0131\u015fla 38,3 milyon $ oldu<\/li>\n<li><strong>\u00c7\u0131\u011f\u0131r A\u00e7an Tedavi:<\/strong> VYJUVEK, distrofik epidermolizis b\u00fclloza i\u00e7in FDA onayl\u0131 ilk gen terapisidir ve s\u00fcrd\u00fcr\u00fclebilir gelir sa\u011flar<\/li>\n<li><strong>\u0130la\u00e7 Aday\u0131 \u0130lerlemesi:<\/strong> KB707 akci\u011fer kanseri i\u00e7in inhalasyon program\u0131 %36 objektif yan\u0131t oran\u0131 ve m\u00fckemmel g\u00fcvenlik profili g\u00f6steriyor (<a href=\"https:\/\/www.pharmanow.live\/latest-news\/kb707-lung-cancer-update\">PharmaNow<\/a>)<\/li>\n<li><strong>Analist Deste\u011fi:<\/strong> Artan &#8220;G\u00fc\u00e7l\u00fc Al&#8221; derecelendirmeleri ile kurumsal g\u00fcven art\u0131yor<\/li>\n<li><strong>Sekt\u00f6r R\u00fczgarlar\u0131:<\/strong> Gen terapisi pazar\u0131n\u0131n \u00f6n\u00fcm\u00fczdeki \u00fc\u00e7 y\u0131lda y\u0131ll\u0131k %26 b\u00fcy\u00fcmesi bekleniyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<p>T\u00fcm bu fakt\u00f6rlerin analizine dayanarak, i\u015fte tavsiyelerim:<\/p>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5&#8217;inden fazla olmayan bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/li>\n<li><strong>Ortalama Maliyetle Al\u0131m Yap\u0131n<\/strong>: T\u00fcm al\u0131m\u0131 tek seferde yapmak yerine, giri\u015f fiyat\u0131n\u0131z\u0131 ortalamak i\u00e7in al\u0131\u015flar\u0131n\u0131z\u0131 birka\u00e7 haftaya yay\u0131n<\/li>\n<li><strong>Zarar Durdur Seviyeleri Belirleyin<\/strong>: Volatilite nedeniyle, yat\u0131r\u0131m\u0131 korumak i\u00e7in 135-140 $ civar\u0131nda zarar durdur seviyesi koyun<\/li>\n<li><strong>3 Kas\u0131m&#8217;\u0131 Takip Edin<\/strong>: Bir sonraki kazan\u00e7 raporu, ge\u00e7ici bir zay\u0131fl\u0131k varsa daha iyi bir giri\u015f noktas\u0131 sa\u011flayabilir<\/li>\n<\/ol>\n<p>Esprili t\u00fcccar bilgeli\u011fi: &#8220;Biyoteknoloji hissesi almak, fl\u00f6rt etmek gibidir &#8211; uzun vadeli ili\u015fki \u00f6d\u00fcllerinin tad\u0131n\u0131 \u00e7\u0131karmak i\u00e7in bazen dramaya katlanmak gerekir!&#8221;<\/p>\n<h2>\u2705 Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ listeli hisseleri sunan ve makul \u00fccretlere sahip oldu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 A\u00e7\u0131n ve Fonlay\u0131n<\/td>\n<td>Risk almaya rahat oldu\u011funuz bir miktarla ba\u015flay\u0131n &#8211; 100 $ bile ba\u015flang\u0131\u00e7 i\u00e7in yeterlidir<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;KRYS&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>Sadece \u015firket ad\u0131 de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Piyasa emirleri yerine giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emir kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Onaylay\u0131n<\/td>\n<td>Emir detaylar\u0131n\u0131 ve komisyon \u00fccretlerini iki kez kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Fiyat Uyar\u0131lar\u0131 Kurun<\/td>\n<td>B\u00fcy\u00fck fiyat hareketleri i\u00e7in otomatik bildirimlerle yat\u0131r\u0131m\u0131n\u0131z\u0131 takip edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>\u00c7\u0131k\u0131\u015f Stratejinizi Planlay\u0131n<\/td>\n<td>K\u00e2r almay\u0131 veya zarar\u0131 durdurmay\u0131 \u00f6nceden belirleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Krystal Biotech ile yat\u0131r\u0131m yolculu\u011funa ba\u015flamak isteyenler i\u00e7in Pocket Option birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Sadece 5 $ minimum depozito<\/strong> &#8211; stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in ideal<\/li>\n<li><strong>Y\u0131ld\u0131r\u0131m h\u0131z\u0131nda KYC s\u00fcreci<\/strong> &#8211; sadece bir belge ile dakikalar i\u00e7inde do\u011frulama<\/li>\n<li><strong>Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil y\u00fczlerce para \u00e7ekme y\u00f6ntemi<\/strong><\/li>\n<li><strong>Yeni ba\u015flayanlar i\u00e7in \u00f6zel olarak tasarlanm\u0131\u015f kullan\u0131c\u0131 dostu platform ve e\u011fitim kaynaklar\u0131<\/strong><\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, biyoteknoloji yat\u0131r\u0131m\u0131 hakk\u0131nda \u00f6\u011frenirken pozisyonlar\u0131 kademeli olarak olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Krystal Biotech: Gen Terapisi \u00d6nc\u00fcs\u00fc<\/h2>\n<p>Krystal Biotech, yakla\u015f\u0131k 4,5 milyar $ piyasa de\u011feri ile <strong>ticari a\u015famadaki bir gen terapisi \u015firketi<\/strong> olarak kendini kan\u0131tlam\u0131\u015ft\u0131r (<a href=\"https:\/\/www.bccresearch.com\/company-index\/profile\/krystal-biotech-inc\">BCC Research<\/a>). \u015eirket, nadir hastal\u0131klar i\u00e7in genetik ila\u00e7lar geli\u015ftirmede HSV-1 vekt\u00f6r teknolojisini kullanmaktad\u0131r.<\/p>\n<p><strong>Onlar\u0131 \u00f6zel k\u0131lan nedir?<\/strong> STAR-D platformlar\u0131, hastalar\u0131n ba\u011f\u0131\u015f\u0131kl\u0131k direnci geli\u015ftirmeden birden fazla tedavi alabilmesini sa\u011flayan tekrarlanabilir gen terapileri sunar; bu alanda b\u00fcy\u00fck bir at\u0131l\u0131md\u0131r.<\/p>\n<p>\u015eirketin amiral gemisi \u00fcr\u00fcn\u00fc VYJUVEK, distrofik epidermolizis b\u00fclloza i\u00e7in <strong>FDA onayl\u0131 ilk gen terapisidir<\/strong>; bu, a\u011fr\u0131l\u0131 ve sakatlay\u0131c\u0131 genetik bir cilt hastal\u0131\u011f\u0131d\u0131r. Ancak as\u0131l heyecan, \u00f6zellikle erken a\u015famalarda ola\u011fan\u00fcst\u00fc sonu\u00e7lar g\u00f6steren KB707 program\u0131ndan gelmektedir.<\/p>\n<h3>\u0130lgin\u00e7 Bilgi:<\/h3>\n<p>A\u011fustos 2025&#8217;te Krystal Biotech, yo\u011fun tedavi g\u00f6rm\u00fc\u015f hastalarda %36 yan\u0131t oran\u0131 g\u00f6steren inhalasyon yoluyla uygulanan KB707 akci\u011fer kanseri tedavisini \u00f6nceliklendirdi. Ger\u00e7ekten dikkat \u00e7ekici olan nedir? Bu tedavi, ciddi yan etkisi olmadan ayaktan tedavi ortam\u0131nda uygulanabiliyor &#8211; bu da kanser tedavisi eri\u015filebilirli\u011finde devrim yaratabilir (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/21\/3137361\/0\/en\/Krystal-Biotech-Announces-Update-on-Development-Plans-for-Oncology-Program-KB707-and-Prioritization-of-Inhaled-KB707-for-the-Treatment-of-Non-Small-Cell-Lung-Cancer.html\">GlobeNewswire<\/a>).<\/p>\n"},"faq":[{"question":"Krystal Biotech hisseleri nas\u0131l al\u0131n\u0131r?","answer":"Bir borsa platformu se\u00e7in, hesab\u0131n\u0131z\u0131 a\u00e7\u0131p fonlay\u0131n, \"KRYS\" sembol\u00fc ile arama yap\u0131n, limit emir kullanarak al\u0131m yap\u0131n ve yat\u0131r\u0131m\u0131n\u0131z\u0131 fiyat uyar\u0131lar\u0131 ile takip edin."},{"question":"KRYS hissesinin riskleri nelerdir?","answer":"Y\u00fcksek volatilite, d\u00fczenleyici belirsizlikler, klinik deneme riskleri ve piyasa duyarl\u0131l\u0131\u011f\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"Krystal Biotech'in en \u00f6nemli \u00fcr\u00fcn\u00fc nedir?","answer":"VYJUVEK, distrofik epidermolizis b\u00fclloza i\u00e7in FDA onayl\u0131 ilk gen terapisidir."},{"question":"2025-2030 aras\u0131nda KRYS hissesinin fiyat beklentisi nedir?","answer":"2025 sonunda 168-172 $, 2026'da 190-195 $, 2028'de 240-260 $ ve 2030'da 295-320 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Yeni ba\u015flayanlar i\u00e7in yat\u0131r\u0131m tavsiyeniz nedir?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, ortalama maliyetle al\u0131m yap\u0131n, zarar durdur seviyeleri belirleyin ve \u00f6nemli kazan\u00e7 raporlar\u0131n\u0131 takip edin."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Krystal Biotech hisseleri nas\u0131l al\u0131n\u0131r?","answer":"Bir borsa platformu se\u00e7in, hesab\u0131n\u0131z\u0131 a\u00e7\u0131p fonlay\u0131n, \"KRYS\" sembol\u00fc ile arama yap\u0131n, limit emir kullanarak al\u0131m yap\u0131n ve yat\u0131r\u0131m\u0131n\u0131z\u0131 fiyat uyar\u0131lar\u0131 ile takip edin."},{"question":"KRYS hissesinin riskleri nelerdir?","answer":"Y\u00fcksek volatilite, d\u00fczenleyici belirsizlikler, klinik deneme riskleri ve piyasa duyarl\u0131l\u0131\u011f\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"Krystal Biotech'in en \u00f6nemli \u00fcr\u00fcn\u00fc nedir?","answer":"VYJUVEK, distrofik epidermolizis b\u00fclloza i\u00e7in FDA onayl\u0131 ilk gen terapisidir."},{"question":"2025-2030 aras\u0131nda KRYS hissesinin fiyat beklentisi nedir?","answer":"2025 sonunda 168-172 $, 2026'da 190-195 $, 2028'de 240-260 $ ve 2030'da 295-320 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Yeni ba\u015flayanlar i\u00e7in yat\u0131r\u0131m tavsiyeniz nedir?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, ortalama maliyetle al\u0131m yap\u0131n, zarar durdur seviyeleri belirleyin ve \u00f6nemli kazan\u00e7 raporlar\u0131n\u0131 takip edin."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Krystal Biotech, Inc. (KRYS) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Krystal Biotech, Inc. (KRYS) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T11:23:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-25T11:23:31+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Krystal Biotech, Inc. (KRYS) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T11:23:30+00:00\",\"dateModified\":\"2025-08-25T11:23:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/\",\"name\":\"Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Krystal Biotech, Inc. (KRYS) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"datePublished\":\"2025-08-25T11:23:30+00:00\",\"dateModified\":\"2025-08-25T11:23:31+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Krystal Biotech, Inc. (KRYS) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Krystal Biotech, Inc. (KRYS) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/","og_locale":"tr_TR","og_type":"article","og_title":"Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Krystal Biotech, Inc. (KRYS) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T11:23:30+00:00","article_modified_time":"2025-08-25T11:23:31+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Krystal Biotech, Inc. (KRYS) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T11:23:30+00:00","dateModified":"2025-08-25T11:23:31+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/","name":"Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Krystal Biotech, Inc. (KRYS) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","datePublished":"2025-08-25T11:23:30+00:00","dateModified":"2025-08-25T11:23:31+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-krystal-biotech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Krystal Biotech, Inc. (KRYS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Krystal Biotech, Inc. (KRYS) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":347265,"slug":"how-to-buy-krystal-biotech","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Krystal Biotech, Inc. (KRYS)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-krystal-biotech\/"},"pt_AA":{"locale":"pt_AA","id":347258,"slug":"how-to-buy-krystal-biotech","post_title":"Como comprar a\u00e7\u00f5es da Krystal Biotech, Inc. (KRYS) - Investimento em a\u00e7\u00f5es da Krystal Biotech, Inc. (KRYS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-krystal-biotech\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/347257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=347257"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/347257\/revisions"}],"predecessor-version":[{"id":347259,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/347257\/revisions\/347259"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334009"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=347257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=347257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=347257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}